# BioMarin Pharmaceutical Inc. (BMRN)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/BMRN/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2026 | $ 1.76B | $ 150.29M | $ 339.02M | $ 4.20B | $ 6.32B |
| 2025 | $ 3.30B | $ 357.24M | $ 736.86M | $ 642.87M | $ 6.09B |
| 2024 | $ 3.00B | $ 448.66M | $ 499.71M | $ 602.71M | $ 5.66B |
| 2023 | $ 2.62B | $ 181.27M | $ 55.84M | $ 1.10B | $ 4.95B |
| 2022 | $ 2.34B | $ 158.14M | $ 49.56M | $ 1.09B | $ 4.60B |
| 2021 | $ 2.19B | $ -76.17M | $ 224.61M | $ 1.09B | $ 4.27B |
| 2020 | $ 2.37B | $ 1.09B | $ -46.21M | $ 1.09B | $ 4.11B |
| 2019 | $ 2.20B | $ -30.78M | $ -135.64M | $ 858.82M | $ 3.12B |
| 2018 | $ 1.97B | $ -101.97M | $ -164.31M | $ 830.42M | $ 2.97B |
| 2017 | $ 1.77B | $ -157.67M | $ -280.17M | $ 1.17B | $ 2.81B |
| 2016 | $ 1.54B | $ -850.54M | $ -517.61M | $ 683.24M | $ 2.77B |
| 2015 | $ 1.25B | $ -241.21M | $ -630.90M | $ 662.29M | $ 2.40B |
| 2014 | $ 1.06B | $ -189.30M | $ -271.83M | $ 642.90M | $ 1.53B |
| 2013 | $ 780.08M | $ -250.82M | $ -177.44M | $ 655.57M | $ 1.34B |
| 2012 | $ 722.92M | $ -165.09M | $ -38.93M | $ 348.22M | $ 1.02B |
| 2011 | $ 648.42M | $ -79.09M | $ -199.02M | $ 348.33M | $ 773.05M |
| 2010 | $ 569.72M | $ 311.64M | $ -46.51M | $ 377.52M | $ 717.26M |
| 2009 | $ 491.58M | $ -740.4K | $ -3.13M | $ 497.08M | $ 322.19M |
| 2008 | $ 448.93M | $ 46.68M | $ -99.24M | $ 638.57M | $ 276.68M |
| 2007 | $ 184.09M | $ -23.93M | $ -86.17M | $ 503.68M | $ 187.73M |
| 2006 | $ 127.50M | $ -43.20M | $ -95.35M | $ 230.73M | $ 117.80M |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 0.66 |
| Liabilities / Eq | 0.85 |
| Current Ratio | 2.39 |

## Debt coverage

| Indicator | Value |
| --- | --- |
| Gross Debt / Earnings | 22.55 |
| Gross Debt / FCF | 36.28 |

## Other views

- [Metrics](https://sponda.capital/en/BMRN.md)
- [Charts](https://sponda.capital/en/BMRN/charts.md)
- [Compare](https://sponda.capital/en/BMRN/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-29.